HIV pill study for kids pulled before it began
NCT ID NCT06139796
First seen Oct 31, 2025 · Last updated May 25, 2026 · Updated 23 times
Summary
This study aimed to find the right dose of a new HIV pill for children aged 3 and older weighing 22 to 55 pounds. The pill combines two medicines to control HIV. However, the study was withdrawn before any participants were enrolled, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Baylor College of Medicine Children's Foundation
Kampala, Uganda, 72052, Uganda
-
Centre Hospitalier National d'Enfants Albert Royer
Dakar, Senegal, 25755, Senegal
-
Centre Mère et Enfant de la Fondation Chantal Biya
Yaoundé, Cameroon, 1, Cameroon
-
Joint Clinical Research Centre (JCRC)
Kampala, Uganda
-
University of Zimbabwe Clinical Research Centre (UZCRC)
Harare, Zimbabwe, Zimbabwe
Conditions
Explore the condition pages connected to this study.